Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Použití systému bioindukčních implantátů REGENETEN™ u vysoce kvalitních slz částečné tloušťky (IMPACT)

23. září 2026 aktualizováno: Smith & Nephew, Inc.

Hodnocení bezpečnosti a účinnosti vstřebatelného kolagenového implantátu při léčbě slz s vysokou částečnou tloušťkou; Prospektivní, multicentrická, randomizovaná, kontrolní studie (studie IMPACT)

The purpose of the study is to assess whether the REGENETEN™ Bioinductive Implant allows patients to get back to their everyday activities quicker than if the tendon is repaired by the standard repair technique 'Completion and Repair' for surgically treating partial-thickness rotator cuff tears.

Přehled studie

Postavení

Nábor

Podmínky

Intervence / Léčba

Detailní popis

The primary objective of this study is to evaluate the functional recovery of patients with high grade (>50%) partial thickness tears at 3 months when treated with either Isolated Bioinductive Repair (IBR) or Completion and Repair (CAR).

Typ studie

Intervenční

Zápis (Odhadovaný)

234

Fáze

  • Nelze použít

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní kontakt

Studijní záloha kontaktů

Studijní místa

  • Austrálie
    • Victoria
      • Richmond, Victoria, Austrálie, 3121
        • Nábor
        • OrthoSport Victoria
        • Vrchní vyšetřovatel:
          • Soong Chua
        • Kontakt:
          • Haydn Klemm
  • Itálie
      • Milan, Itálie
        • Nábor
        • IRCCS Istituto Ortopedico Galeazzi,
        • Kontakt:
          • Vincenzo Guarrella
        • Vrchní vyšetřovatel:
          • Ettore Taverna
      • Roma, Itálie
        • Nábor
        • Fondazione Policlinico Universitario Campus Bio-Medico
        • Kontakt:
          • Giuseppe Longo
        • Vrchní vyšetřovatel:
          • Giuseppe Longo
  • Kanada
    • Alberta
      • Calgary, Alberta, Kanada, T2R 2G5
        • Nábor
        • Access Orthopaedics
        • Kontakt:
          • Kristie More
        • Vrchní vyšetřovatel:
          • Ian Lo
    • Manitoba
      • Winnipeg, Manitoba, Kanada
        • Aktivní, ne nábor
        • Pan Am Clinic
    • Ontario
      • Hamilton, Ontario, Kanada
        • Nábor
        • Research St. Joseph's
        • Vrchní vyšetřovatel:
          • Moin Khan
        • Kontakt:
          • Danielle Dagher
  • Spojené království
      • Bath, Spojené království
        • Nábor
        • Sulis Hospital
        • Vrchní vyšetřovatel:
          • Andrew Chambler
      • Bristol, Spojené království
        • Nábor
        • North Bristol NHS Trust
        • Kontakt:
          • Steven Barnfield
        • Vrchní vyšetřovatel:
          • Iain Packham
      • Salford, Spojené království, M6 8HD
        • Staženo
        • Northern Care Alliance NHS Foundation Trust
    • Surrey
      • Chertsey, Surrey, Spojené království, KT16 0PZ
        • Nábor
        • Ashford & St Peter's Hospitals NHS Foundation Trust
        • Vrchní vyšetřovatel:
          • Ali Narvani
        • Kontakt:
          • Timnit Tekie
  • Spojené státy
    • Georgia
      • Rome, Georgia, Spojené státy, 30165
        • Nábor
        • Harbin Clinic
        • Vrchní vyšetřovatel:
          • Brandon Bushnell
        • Kontakt:
          • Terri Brannon
    • Illinois
      • Rockford, Illinois, Spojené státy, 61107
        • Nábor
        • OrthoIllinois LTD
        • Vrchní vyšetřovatel:
          • Scott Trenhaile
        • Kontakt:
          • Catherine Ayala
    • Maryland
      • Baltimore, Maryland, Spojené státy, 21215
        • Staženo
        • Sinai Hospital Baltimore
    • Ohio
      • Garfield Heights, Ohio, Spojené státy, 44125
        • Staženo
        • Cleveland Clinic - Sports Health
    • Pennsylvania
      • Pittsburgh, Pennsylvania, Spojené státy, 15213
        • Nábor
        • University of Pittsburgh
        • Vrchní vyšetřovatel:
          • Albert Lin
        • Kontakt:
          • Alec Howard
    • Texas
      • Bedford, Texas, Spojené státy, 76021
        • Aktivní, ne nábor
        • Texas Orthopedic Specialists
      • The Woodlands, Texas, Spojené státy, 77385
        • Staženo
        • Houston Methodist The Woodlands
    • Wisconsin
      • Ashland, Wisconsin, Spojené státy, 54806
        • Staženo
        • Memorial Medical Center
  • Španělsko
      • Madrid, Španělsko, 28034
        • Nábor
        • Hospital Ramón y Cajal
        • Kontakt:
          • Miguel Angel Ruiz Iban
        • Vrchní vyšetřovatel:
          • Miguel Angel Ruiz Iban
      • Madrid, Španělsko, 28040
        • Nábor
        • Hospital Fundación Jiménez Díaz
        • Kontakt:
          • Cristina Delgado del Cano
        • Vrchní vyšetřovatel:
          • Emilio Calvo

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

18 let a starší (Dospělý, Starší dospělý)

Přijímá zdravé dobrovolníky

Ne

Pohlaví způsobilá ke studiu

Všechno

Popis

Inclusion Criteria:

  • The subject must provide written informed consent.
  • Subject is > eighteen (18) years of age (no upper limit).
  • Subject has an isolated high-grade (>50% or >6mm) (Ellman grade III) partial thickness tear of supraspinatus or supraspinatus with infraspinatus.
  • Subject has failed a minimum of 3 months of conservative management for treatment of partial thickness rotator cuff tear.
  • Subject willing and able to make all required study visits.
  • Subject able to follow instructions and deemed capable of completing all study questionnaires.

Exclusion Criteria:

  • Subjects with insufficient tendon tissue quality for management and protection of the tendon injury using the isolated REGENETEN Bioinductive Implant system.
  • Subjects where the prescribed Physical Therapy guidelines stated in the protocol are not suitable for their rehabilitation.
  • Subjects with Samilson-Prieto osteoarthritis grade 2 and greater.
  • Subjects with current or prior infection of the ipsilateral shoulder.
  • Subjects with known hypersensitivity to bovine-derived materials.
  • Subjects with known inflammatory arthropathy, history of inflammatory arthropathy, chronic joint disease or chronic pain of upper extremities (shoulder(s), arm(s)).
  • Subjects with prior shoulder surgery on index shoulder, including subacromial decompression, biceps tenodesis/tenotomy, and acromioclavicular joint (ACJ) excision/distal clavicle excision (DCE).
  • Subjects with a planned surgery on the contra-lateral shoulder within the study period.
  • Systemic steroid use (oral, IV) or local steroid injection within 3 months of the date of surgery.
  • Subjects with a full thickness rotator cuff tear.
  • Subjects with a subscapularis tear requiring repair.
  • Subjects requiring a concomitant labral fixation procedure, concomitant surgery for bone defects requiring bone implantation or for superior labral tear from anterior to posterior (SLAP).
  • Subjects requiring a concomitant os acromiale fixation procedure.
  • Subjects with glenohumeral joint instability (multiple dislocations/subluxations).
  • Subjects with condition(s) that contraindicate or complicate outcomes of Isolated Bioinductive Repair or completion and repair e.g., > Hamada 3 rotator cuff arthropathy on X-ray, Goutallier atrophy > Grade 3, proximal humeral fracture or scapular fracture, avascular necrosis of the humeral head.
  • Subjects with neurologic conditions effecting either upper extremity.
  • Subjects who are unable to tolerate magnetic resonance imaging (MRI), due to psychiatric or medical contraindications.
  • Subjects who are pregnant or breast feeding.
  • Subjects who are currently involved in any injury litigation relating to the index shoulder.
  • Subjects with current workers compensation claim.
  • Subjects who are enrolled, or plan to enroll, in another clinical trial during this study that would affect the outcomes of this study.
  • Subjects with a history of poor compliance with medical treatment, physical therapy (PT)/rehabilitation, or clinical study participation.
  • Subject who, in the opinion of the Investigator, has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, mental retardation, and drug or alcohol abuse.
  • Subjects who do not meet the indication or are contraindicated according to specific Smith+Nephew REGENETEN System's Instructions for Use (IFUs).
  • Any subject that meets the definition of a Vulnerable Subject per ISO 14155 Section 3.55.
  • Subjects who have participated previously in this clinical trial and who have healed or been withdrawn
  • Subjects with a medical or physical condition that, in the opinion of the Investigator, would preclude safe subject participation in the study.

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Primární účel: Léčba
  • Přidělení: Randomizované
  • Intervenční model: Paralelní přiřazení
  • Maskování: Singl

Zbraně a zásahy

Skupina účastníků / Arm
Intervence / Léčba
Experimentální: Isolated Bioinductive Repair

Surgical treatment of partial-thickness rotator cuff tears with the REGENETEN Bioinductive Implant system.
Přístroj: Isolated Bioinductive Repair

Isolated Bioinductive repair with REGENETEN™ Bioinductive Implant

Ostatní jména:
  • Bioinduktivní implantát REGENETEN™
Aktivní komparátor: Completion and Repair

Surgical treatment of partial-thickness rotator cuff tears using the standard surgical technique 'Completion and Repair'.
Postup: Completion and Repair

Standard surgical repair using the 'Completion and Repair' technique.

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Change in Western Ontario Rotator Cuff (WORC)
Časové okno: Change from baseline to 3 months post-intervention

The WORC Index is self-administered, and includes a 5 different domains (physical symptoms, sports and recreation, work, social function, and emotions). Each question uses a visual analog scale (VAS) representing a 100-point scale ranging from 0 to 100. The maximum score is 2100 (worst possible symptoms). Zero (0) represents no symptoms at all. The final score can also be presented as a percentage by subtracting the total from 2100, dividing by 2100, and multiplying by 100. This will give you an overall percentage. The total final WORC Index scores can, therefore, range from 0% (lowest functional status level) to 100% (highest functional status level).
Change from baseline to 3 months post-intervention

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Western Ontario Rotator Cuff (WORC)
Časové okno: Pre-op, 6 weeks, 3, 6, 12 and 24 months

The WORC Index is self-administered, and includes a 5 different domains (physical symptoms, sports and recreation, work, social function, and emotions). Each question uses a visual analog scale (VAS) representing a 100-point scale ranging from 0 to 100. The maximum score is 2100 (worst possible symptoms). Zero (0) represents no symptoms at all. The final score can also be presented as a percentage by subtracting the total from 2100, dividing by 2100, and multiplying by 100. This will give you an overall percentage. The total final WORC Index scores can, therefore, range from 0% (lowest functional status level) to 100% (highest functional status level).
Pre-op, 6 weeks, 3, 6, 12 and 24 months
Constant-Murley Score
Časové okno: Pre-Op, 3, 6, 12 and 24 months

The Constant-Murley Score is a validated assessment of pain and shoulder functionality. The Constant Score is divided into 4 subscales: pain (15 points; VAS score range of 0-15), activities of daily living (20 points; range 0=worst, 5=best), strength (25 points; 1 point given per 0.5 kg of weights raised), and range of motion - forward flexion, external rotation, abduction and internal rotation of the shoulder (40 points; range 0=worst, 10=best). The higher the score, the higher the quality of function.
Pre-Op, 3, 6, 12 and 24 months
Subjective Shoulder Value (SSV) score
Časové okno: Pre-Op, 6 weeks, 3, 12 and 24 months

The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100% (0% to 100% scale with 100% being normal).
Pre-Op, 6 weeks, 3, 12 and 24 months
EuroQol 5 Dimension 5 Level (EQ-5D-5L) VAS & index scores
Časové okno: Pre-Op, 3 and 6 weeks, 3, 6, 12 and 24 months

To assess the subject's health state. The EQ-5D-5L is composed of the EQ- 5D-5L descriptive system and the EQ Visual Analogue scale (EQ VAS).

The descriptive system comprises 5 dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression). Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Responses are coded as single-digit numbers expressing the severity level selected in each dimension. For instance, 'slight problems' (e.g. 'I have slight problems in walking about') is always coded as '2'. The digits for the five dimensions are combined in a 5-digit code. The EQ- 5D-5L index value is derived by using the vendor supplied calculator to convert each 5-digit EQ- 5D-5L profile.

The EQ VAS corresponds to a 20 cm vertical, visual analogue scale ranging from 'the best health you can imagine' to 'the worst health you can imagine'.

A higher number is a better outcome.
Pre-Op, 3 and 6 weeks, 3, 6, 12 and 24 months
Change in Western Ontario Rotator Cuff (WORC)
Časové okno: Change from Pre-op to 6 weeks, 3, 6, 12 and 24 months

The WORC Index is self-administered, and includes a 5 different domains (physical symptoms, sports and recreation, work, social function, and emotions). Each question uses a visual analog scale (VAS) representing a 100-point scale ranging from 0 to 100. The maximum score is 2100 (worst possible symptoms). Zero (0) represents no symptoms at all. The final score can also be presented as a percentage by subtracting the total from 2100, dividing by 2100, and multiplying by 100. This will give you an overall percentage. The total final WORC Index scores can, therefore, range from 0% (lowest functional status level) to 100% (highest functional status level).
Change from Pre-op to 6 weeks, 3, 6, 12 and 24 months
Change in Constant-Murley Score
Časové okno: Change from Pre-Op to 6 weeks, 3, 12 and 24 months

The Constant-Murley Score is a validated assessment of pain and shoulder functionality. The Constant Score is divided into 4 subscales: pain (15 points; VAS score range of 0-15), activities of daily living (20 points; range 0=worst, 5=best), strength (25 points; 1 point given per 0.5 kg of weights raised), and range of motion - forward flexion, external rotation, abduction and internal rotation of the shoulder (40 points; range 0=worst, 10=best). The higher the score, the higher the quality of function.
Change from Pre-Op to 6 weeks, 3, 12 and 24 months
Change in Subjective Shoulder Value (SSV) score
Časové okno: Change from Pre-Op to 6 weeks, 3, 12 and 24 months

The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100% (0% to 100% scale with 100% being normal).
Change from Pre-Op to 6 weeks, 3, 12 and 24 months
Percent Achieving Minimal Clinically Important Difference (MCID) for Constant-Murley Score
Časové okno: Pre-Op, 3, 6, 12 and 24 months

The Constant-Murley Score is a validated assessment of pain and shoulder functionality. The Constant Score is divided into 4 subscales: pain (15 points; VAS score range of 0-15), activities of daily living (20 points; range 0=worst, 5=best), strength (25 points; 1 point given per 0.5 kg of weights raised), and range of motion - forward flexion, external rotation, abduction and internal rotation of the shoulder (40 points; range 0=worst, 10=best). The higher the score, the higher the quality of function.
Pre-Op, 3, 6, 12 and 24 months
Percent Achieving MCID for Western Ontario Rotator Cuff (WORC)
Časové okno: Pre-op, 6 weeks, 3, 6, 12 and 24 months

The WORC Index is self-administered, and includes a 5 different domains (physical symptoms, sports and recreation, work, social function, and emotions). Each question uses a visual analog scale (VAS) representing a 100-point scale ranging from 0 to 100. The maximum score is 2100 (worst possible symptoms). Zero (0) represents no symptoms at all. The final score can also be presented as a percentage by subtracting the total from 2100, dividing by 2100, and multiplying by 100. This will give you an overall percentage. The total final WORC Index scores can, therefore, range from 0% (lowest functional status level) to 100% (highest functional status level).
Pre-op, 6 weeks, 3, 6, 12 and 24 months
Percent Achieving MCID for Subjective Shoulder Value (SSV) score
Časové okno: Pre-Op, 6 weeks, 3, 12 and 24 months

The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100% (0% to 100% scale with 100% being normal).
Pre-Op, 6 weeks, 3, 12 and 24 months
Patient Satisfaction
Časové okno: 6 weeks, 3, 6, 12 and 24 months

Comprise of 2 questions:

  1. Overall, I am satisfied with the outcome of my surgery
  2. I would recommend the procedure to a friend.

Question rated by the patient with Strongly Agree, Agree, Neither Agree nor Disagree, Disagree, Strongly Disagree.
6 weeks, 3, 6, 12 and 24 months
Pain, Visual analog scale (VAS) Score
Časové okno: Pre-Op, 3 and 6 weeks, 3, 12 and 24 months

Pain is assessed on a 100-point scale ranging from 0 to 100, with zero (0) representing no pain and 100 representing the worst pain imaginable.
Pre-Op, 3 and 6 weeks, 3, 12 and 24 months
MRI Tendon Findings in subjects with Isolated Bioinductive Repair versus completion via Sugaya Score
Časové okno: 12 months

The Sugaya score is classified into 5 categories: Type I to Type V. Type I indicates sufficient thickness with homogenously low intensity. Type II indicates sufficient thickness with partial high intensity. Type III indicates insufficient thickness without discontinuity. Type IV indicates presence of a minor discontinuity, suggesting a small full-thickness tear. Type V indicates the presence of a major discontinuity, suggesting a medium or large full-thickness tear.
12 months
MRI Tendon Findings in subjects with Isolated Bioinductive Repair versus completion via MRI assessment of percent filling
Časové okno: 12 months

Percent tissue infil is graded at site of original tear and classified as 0% to < 25%, 25% to < 50%, 50% to < 75%, 75% to < 100% and 100%.
12 months
MRI Tendon Findings in subjects with Isolated Bioinductive Repair versus completion via MRI assessment of the signal intensity pattern
Časové okno: 12 months

The Signal Intensity Pattern will be graded into 3 categories. Type I: Heterogeneous high signal intensity with fluid-like bright foci, Type II: Heterogeneous high signal intensity without fluid-like bright foci, Type III: Heterogeneous or homogeneous low signal intensity.
12 months
MRI Tendon Findings in subjects with Isolated Bioinductive Repair versus completion via Rotator cuff tendon thickness
Časové okno: 12 months

Tendon thickness will be measured in millimeters (mm).
12 months
MRI Tendon Findings in subjects with Isolated Bioinductive Repair versus completion via Goutallier classification
Časové okno: 12 months

The Goutallier classification will be used to classify the fatty infiltration of the rotator cuff. The Goutallier classification ranges from a grade of 0 indicating a completely normal muscles without any fatty streaks to a grade of 4 which indicates that more fat than muscle is present.
12 months
Incidence of Revision Surgery
Časové okno: 1, 3 and 6 weeks, 3, 6, 12 and 24 months

Number of subjects requiring revision surgery
1, 3 and 6 weeks, 3, 6, 12 and 24 months
Time to return to work
Časové okno: Up to 24 months

Number of weeks taken to return to work following surgery
Up to 24 months
Time to return to driving
Časové okno: Up to 24 months

Number of weeks taken to return to driving following surgery
Up to 24 months
Time to return to sports
Časové okno: Up to 24 months

Number of weeks taken to return to sport following surgery
Up to 24 months
Total operative time
Časové okno: Inter-operative time

Time expressed in minutes
Inter-operative time
Physical Therapy Utilization
Časové okno: Up to 24 months

Number visits following index surgery
Up to 24 months
Cumulative days of opioid use
Časové okno: Day 1-14

Self-reported opioid use diary completed by the patient on a daily basis, from day 0-14, documenting opioid use. Consumption daily (YES/NO) x14 days, 'Have you taken any opioid medication today for shoulder pain?'
Day 1-14
Duration of shoulder immobilization following index surgery
Časové okno: 1, 3 and 6 weeks, 3 months

Number of days
1, 3 and 6 weeks, 3 months

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Sponzor

Smith & Nephew, Inc.

Vyšetřovatelé

  • Studijní židle: Laura Mills, Smith & Nephew, Inc.

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Aktuální)

30. srpna 2022

Primární dokončení (Odhadovaný)

15. dubna 2027

Dokončení studie (Odhadovaný)

28. února 2029

Termíny zápisu do studia

První předloženo

29. června 2022

První předloženo, které splnilo kritéria kontroly kvality

29. června 2022

První zveřejněno (Aktuální)

6. července 2022

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

28. září 2026

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

23. září 2026

Naposledy ověřeno

1. září 2026

Více informací

Termíny související s touto studií

Klíčová slova

Další relevantní podmínky MeSH

Další identifikační čísla studie

  • REGENETEN.2021.04

Plán pro data jednotlivých účastníků (IPD)

Plánujete sdílet data jednotlivých účastníků (IPD)?

NE

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ne

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ano

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Předplatit